Survey on Cardiogenic Shock and the Use of ECMO and Impella in Spanish Cardiac Critical Care Units

Simple item page
dc.contributor.authorGarcía Carreño, Jorge
dc.contributor.authorMartínez-Solano, Jorge
dc.contributor.authorSousa, Iago
dc.contributor.authorJuárez-Fernández, Miriam
dc.contributor.authorMartínez-Sellés D Oliveira Soares, Manuel
dc.date.accessioned2024-04-24T14:40:42Z
dc.date.available2024-04-24T14:40:42Z
dc.date.issued2023-06-21
dc.description.abstractBackground: Previous studies suggest variability in the management of cardiogenic shock (CS). Methods: An anonymous survey was sent to Spanish hospitals. Results: We obtained 50 answers, mainly from cardiologists (36–72%). The annual average of ECMOs is 16.7 ± 11.3 applications in CS patients and of Impellas is 8.7 ± 8.3 applications in CS patients. Intra-aortic balloon counterpulsation is used in the majority of CS ECMOs (31–62%), and Impella is used in 7 (14%). In 36 (72%) cases, ECMO is used as a treatment for cardiac arrest. In 10 cases, ECMO removal is percutaneous (20%). In 25 (50%) cases, age is a relative contraindication; 17 have a mobile ECMO team (34%); and 23 (46%) have received ECMO patients from other centers in the last year. Pre-purged ECMO is only used in 16 (32%). ECMO implantation is carried out under ultrasound guidance in 31 (62%), only with angiography in 3 (6%) and with both in 11 (22%). The Swan–Ganz catheter is used routinely in 8 (16%), only in doubtful cases in 24 (48%), and in most cases in 8 (16%). The ECMO awake strategy is used little or not at all in 28 (56%), in selected cases in 17 (34%), and routinely in 5 (10%). Conclusion: Our study shows a huge variation in the management of patients with CS.
dc.description.departmentDepto. de Medicina
dc.description.facultyFac. de Medicina
dc.description.fundingtypeDescuento UCM
dc.description.refereedTRUE
dc.description.statuspub
dc.identifier.citationMartínez-Sellés, M.; García Carreño, J.; Martínez-Solano, J.; Sousa, I.; Juárez-Fernández, M. Survey on Cardiogenic Shock and the Use of ECMO and Impella in Spanish Cardiac Critical Care Units. J. Vasc. Dis. 2023, 2, 299-309. https://doi.org/10.3390/jvd2030022
dc.identifier.doi10.3390/jvd2030022
dc.identifier.officialurl10.3390/jvd2030022
dc.identifier.relatedurlhttps://www.mdpi.com/2813-2475/2/3/22
dc.identifier.urihttps://hdl.handle.net/20.500.14352/103452
dc.issue.number3
dc.journal.titleJournal of Vascular Diseases
dc.language.isoeng
dc.page.final309
dc.page.initial299
dc.publisherMPDI
dc.rightsAttribution 4.0 Internationalen
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subject.cdu616.12
dc.subject.keywordCardiogenic shock
dc.subject.keywordECMO
dc.subject.keywordImpella
dc.subject.keywordSurvey
dc.subject.ucmCardiología
dc.subject.unesco3205.01 Cardiología
dc.titleSurvey on Cardiogenic Shock and the Use of ECMO and Impella in Spanish Cardiac Critical Care Units
dc.typejournal article
dc.type.hasVersionVoR
dc.volume.number2
dspace.entity.typePublication
relation.isAuthorOfPublication36192f36-cf52-43c0-a71f-842039d2ee62
relation.isAuthorOfPublication.latestForDiscovery36192f36-cf52-43c0-a71f-842039d2ee62
Download
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
jvd-02-00022.pdf
Size:
1.15 MB
Format:
Adobe Portable Document Format
downoload Download
Collections
Artículos